Concepedia

Publication | Open Access

Lutetium-177-PSMA-617 in Low-Volume Hormone-Sensitive Metastatic Prostate Cancer: A Prospective Pilot Study

89

Citations

35

References

2021

Year

Abstract

<sup>177</sup>Lu-PSMA appeared to be a feasible and safe treatment modality in patients with low-volume mHSPC.

References

YearCitations

Page 1